DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results
WILMINGTON, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), reported today its corporate highlights and financial results for the first quarter ended March 31, 2012.